Karyopharm Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.62

+0.00 (+0.00%)

As of Sep 28, 10:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +2,933.3% upside

Low Target $31.72

Average Target $49.14

High Target $61.64

Current Price $1.62

Current
$1.62

Target
$49.14

$31.72 $49.14 avg $61.64

Scenario Analysis

Bear Case

$31.72

1,858.0%

Low target

Base Case

$49.14

+2,933.3%

Avg target

Bull Case

$61.64

+3,704.9%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$10.99

-85.3% from high

52-Week Low

$1.24

+30.6% from low

Target vs 52W High

$49.14

+347.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%